Clinical trial
Phase 1 Study of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 Diabetes
NCT01935804 is registered in ClinicalTrials.gov with King Abdulaziz University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Study of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 Diabetes
- Lead sponsor
- King Abdulaziz University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2009
- Completion date
- January 31, 2014
- Enrollment
- 440 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.